Agnes Rafalko is listed as an executive officer and director on 1 SEC Form D filing by 1 issuer in Nov 2016: Glycomine, Inc. (San Francisco, CA — biotechnology — 2016; $4.93M reported sold to 15 investors).
What this means One deal on file with the SEC, filed Nov 2016. A Form D is the notice a company files after it starts selling a private investment — it is a notice, not an approval.
Listed alongside Christopher Starr (1 shared filing), Giacomo Chiesi (1 shared filing) and Peter C.M. McWilliams (1 shared filing).
What this means These are the other officers, directors or promoters the companies named on the same forms — the team around Agnes. Each name links to their own page.
Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AK, AL, AR, AZ, CA, CT, DE, FINRA, GA, HI, ID, IL, KS, KY, LA, MA, MD, ME, MI, MO, MS, MT, NASAA, NC, ND, NH, NM, NV, OK, OR, PA, RI, SC, SD, TN, TX, VT, WA, WI, WV, WY) — 1 court case matching the name, 1 bankruptcy case matching the name listed in Key records below.
What this means 2 records came back. Each one is listed below with a link to the original document and a line saying why it matched. A name match is not proof it is the same person or company — read the why line and the document. Being sued or named in a release is an accusation, not a finding.
We compared 1 public filing for Agnes Rafalko and found 3 differences: Bankruptcy case: Chase Bank USA, N.A. v. Rafalko; Agnes Rafalko appears on 1 deal that stopped filing before reaching its target; and more below.
What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.